Why I’m Still Selling British American Tobacco Plc

British American Tobacco plc (LON: BATS) recently reported interim results. Although earnings and dividends increased, I still believe that the shares are significantly over-valued.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Past success

British American Tobacco (LSE: BATS) (NYSE: BTI.US) is one of the most successful companies in the FTSE 100. The company is a leader in its field, owns a stable of top brands and is financially strong. The company has a £67bn market capitalisation and employs around 87,000 staff worldwide.

In the last five years, BATS has increased revenues at an average rate of 8.7% a year. In that time, earnings per share (EPS) has been rising at an average rate of 13.6%. Dividend growth has been even stronger, increasing at an average rate of 15.3% a year.

Valuation

Cigarette firms have a famously reliable (addicted) customer base. This brings a high degree of visibility to their earnings.

Today, BATS shares are trading at 17.0 times last year’s earnings. With 8.5% EPS growth forecast for the year, pushing the P/E down to 15.7 times the forecast 2013 outcome.

At today’s price, last year’s dividend payout equates to a yield of 3.9%. That is forecast to increase this year, to give a prospective yield of 4.2%.

Recent results

BATS announced its results for the first six months of the year yesterday. The company reported a 7.7% increase in EPS and a 6.6% dividend hike. This is the first time since 2004 that BATS has failed to increase its dividend or EPS at a double-digit rate.

Worse still, revenues for the half-year increased by just 1.6%, while the number of cigarettes sold fell 3.2%. In the Americas, cigarette sales fell 9.9%.

My verdict

It should be noted that in the developed nations, cigarette sales are falling the most. As people have better access to the facts about the dangers of tobacco and governments impose restrictions, sales fall.

I see no sign of this trend stopping. With revenue growth minimal, dividends and earnings cannot continue to rise for much longer. Eventually, I expect that the market will start to price BATS as ex-growth. That could result in the shares being priced on a single-digit P/E.

For income investors, our team of analysts here believe that they have identified a better dividend share than BATS. “The Motley Fool’s Top Income Share For 2013” is a free research report detailing their analysis of another blue-chip opportunity. To get your totally free copy of this report, just click here. It will be delivered to your inbox immediately.

> David does not own shares in any of the companies mentioned. He has bet that the price of shares in British American Tobacco will fall.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »

Tesla car at super charger station
Investing Articles

Why is Tesla stock down 30% since late 2025?

Tesla stock has been a bit of a car crash in 2026. Edward Sheldon looks at what’s going on, and…

Read more »

UK supporters with flag
Investing Articles

Is Wise now the UK stock market’s top growth share?

Wise rose around 4% in the UK stock market yesterday, bringing its four-year gain to 135%. Why are investors warming…

Read more »

Warhammer World gathering
Investing Articles

£20,000 invested in this FTSE 100 stock 10 years ago is now worth this astonishing amount…

This FTSE 100 stock's delivered an amazing return over the past 10 years. James Beard considers whether it’s worth holding…

Read more »